Osteovile (Alfacalcidol)

Alfacalcidol, the active ingredient in Osteovile, is a vitamin D analog presented as a oral formulation for systemic use. It is employed in the management of disorders related to calcium metabolism, particularly in patients with chronic kidney disease.

GNH USA supplies Osteovile as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Osteovile is a vitamin‑D‑type drug that acts on calcium‑phosphate homeostasis. - Renal osteodystrophy: improves calcium absorption and reduces secondary hyper‑parathyroidism in chronic CKD patients. - Hypocalcaemia: raises serum calcium levels when oral vitamin D insuff  - Osteoporosis : con  ??? -   -  -